Facebook Linkedin RSS Twitter Youtube
Home 2023

Spinal muscular atrophy

Going Dutch: VectorY’s $138M Series A to Advance Vectorized Antibody Programs for Neurodegenerative Diseases
Drug Discovery

Going Dutch: VectorY’s $138M Series A to Advance Vectorized Antibody Programs for Neurodegenerative Diseases

Jonathan D Grinstein, PhD -
0
Antibodies Take Center Stage in Alzheimer’s
Drug Discovery

Antibodies Take Center Stage in Alzheimer’s

Kathy Vuksanaj -
0
Making AAVs the Go-To for Making Gene Therapies Go
Drug Discovery

Making AAVs the Go-To for Making Gene Therapies Go

Kathy Vuksanaj -
0
ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing
Genome Editing

ASGCT News: David Liu Hails Rapid Progress in Precision Genome Editing

Kathy Vuksanaj -
35
Antisense Oligonucleotides Help Treat Deadly Brain Cancer in Mice
Cancer

Antisense Oligonucleotides Help Treat Deadly Brain Cancer in Mice

Christina Jackson -
0
One-Time Treatment: Base Editing Shows Promise vs. SMA
Genome Editing

One-Time Treatment: Base Editing Shows Promise vs. SMA

Alex Philippidis -
1
Stoked About ASOs: Stoke Therapeutics Treats Rare CNS Diseases With RNA-Based Medicines
GEN Edge

Stoked About ASOs: Stoke Therapeutics Treats Rare CNS Diseases With RNA-Based Medicines

Jonathan D Grinstein, PhD -
0
Challenges in Biologics R&D
Bioprocessing

Challenges in Biologics R&D

Anjali A. Sarkar, PhD -
2
Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma
Genome Editing

Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma

Alex Philippidis -
0
Scholar Rock: A New Twist on Targeting Growth Factors
Cancer

Scholar Rock: A New Twist on Targeting Growth Factors

Malorye Allison Branca -
0
123...5Page 1 of 5
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.